Allergan Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
4.34 Bil |
| Income |
550.40 Mil |
| Net Profit Margin |
12.73% |
| Return on Equity |
12.89% |
| Debt/Equity Ratio |
0.33 |
|
| Revenue/Share |
14.21 |
| Earnings/Share |
1.80 |
| Book Value/Share |
14.95 |
| Dividend Rate |
0.20 |
| Payout Ratio |
11.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 1,007.2 | 1,076.6 | 876.7 |
| 2nd Qtr | 1,130.8 | 1,172.0 | 977.9 |
| 3rd Qtr | 1,141.3 | 1,098.2 | 993.7 |
| 4th Qtr | NA | 1,056.6 | 1,090.6 |
| Total | 3,279.3 | 4,403.4 | 3,938.9 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.15 | $0.35 | $0.14 |
| 2nd Qtr | $0.58 | $0.47 | $0.45 |
| 3rd Qtr | $0.59 | $0.54 | $0.51 |
| 4th Qtr | NA | $0.50 | $0.52 |
| Total | $1.32 | $1.86 | $1.62 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -70% | -33% | --- |
| 2nd Qtr | 287% | 34% | 221% |
| 3rd Qtr | 2% | 15% | 13% |
| 4th Qtr | NA | -7% | 2% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -57% | 150% |
| 2nd Qtr | 23% | 4% |
| 3rd Qtr | 9% | 6% |
| 4th Qtr | NA | -4% |
advertisement
Recent News